Guidelines for Avoiding Risks Resulting From Discontinuation of Nucleoside/Nucleotide Analogs in Patients With Chronic Hepatitis B

Hepatology Research - United Kingdom
doi 10.1111/hepr.12108
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley